THE BOTTOM LINE
Since October 30, 2026, HHS says it won't take enforcement action against licensed 503A pharmacies and physicians that compound Epitalon acetate for subcutaneous or intramuscular injection, dispensed in intermittent courses, under its conditions. Continuous daily use, oral and nasal products are not covered. Epitalon is not FDA approved, and longevity claims in people are not established.
SIDE-BY-SIDE
What actually differs
What changed on October 28
Epitalon is one of six peptides in HHS's October 28, 2026 enforcement discretion policy. Starting October 30, HHS says it does not intend to act against covered compounders that make Epitalon acetate for injection, dispensed in intermittent courses, under the policy's conditions.
FDA's advisory committee recommended Epitalon for the 503A Bulks List on July 24, 2026. It was nominated for insomnia.
The policy's other conditions apply to every one of the six peptides: the ingredient must come from an FDA-registered facility with a valid certificate of analysis made under CGMP, the product may contain only one active ingredient, the only delivery device allowed is an FDA 510(k)-cleared syringe, the label must say it is a compounded drug not for resale, and serious adverse events must be reported to FDA MedWatch.
What it didn't change
It did not approve the peptide; compounded drugs are not FDA approved. It did not add it to the 503A Bulks List, which still requires formal rulemaking. It does not cover "research use only" vials, blends with other peptides, or any route the policy doesn't list. HHS calls the policy interim and says it can revisit it; public comments are open through November 13, 2026.
Epitalon is the only peptide on the list with a schedule limit: intermittent courses only. The policy doesn't set a dose or course length; that's the prescriber's decision, not a validated regimen.
What Epitalon is, and what the evidence says
Epitalon (also spelled epithalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly. It's popular in longevity circles because of research, much of it from one group in Russia, linking it to telomeres and sleep hormones.
The human studies are small, older and largely from a single research program. Claims that it reverses aging or extends lifespan in people are not established, and long-term human safety is unknown.
Who should slow down
Anyone with a history of cancer, given unanswered questions about effects on cell growth. Anyone pregnant or breastfeeding. Athletes in tested sport should check the WADA list.
Ask any provider: Is a licensed clinician reviewing my case? Which state-licensed 503A pharmacy fills it? Is there a certificate of analysis for the ingredient? Is it this peptide alone, with no blend? Is the route one the policy covers? What's the full price, including refills, and how do I cancel? If anything says "FDA approved," treat that as a red flag.
QUICK ANSWERS
Is Epitalon legal now?
Since October 30, 2026, licensed 503A pharmacies and physicians can compound Epitalon acetate for injection in intermittent courses without federal enforcement, if they meet the HHS policy conditions. It is not FDA approved.
Can Epitalon be taken daily under the policy?
No. The policy covers intermittent courses, not continuous daily use.
PRIMARY & AUTHORITATIVE SOURCES
Check the underlying record
Regulatory status and labeling can change. Sources were reviewed on the article update date; current prescribing information controls.COMPARE THE CARE MODEL
Medication is only one part of the decision.
Use the 30-second filter to identify the costs, clinical safeguards and service terms worth checking before you enroll.
Find my starting point →